Lithos Group Ltd
OTC:LITSD
Relative Value
There is not enough data to reliably calculate the relative value of LITSD.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
LITSD Competitors Multiples
Lithos Group Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Lithos Group Ltd
OTC:LITSD
|
5.3m USD | 0 | -0.3 | -0.3 | -0.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.9B USD | 0.2 | 54 | 13.9 | 13.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.1B EUR | 0.3 | 13.3 | 7.8 | 9.9 | |
| US |
|
Cigna Corp
NYSE:CI
|
71.1B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.3B EUR | 1.1 | 20.6 | 9.7 | 14.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.4B EUR | 1.2 | 23.9 | 9.2 | 17 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD | 1.6 | 25.4 | 12.2 | 17.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.9B USD | 2 | 22.2 | 12.2 | 16.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.2B EUR | 0.6 | 11.5 | 5.5 | 10.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | 11.7 | -27.6 | -30.1 | -27.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 13.9 | 7.2 | 9.7 |